Sensus Healthcare, Inc.
SRTS · NASDAQ
Bulios Fair Price
$2.23
27.4% downside
Preț actual
$3.07
Potrivit Bulios Fair Price, acțiunile SRTS sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Bulios Fair Price este o estimare a valorii corecte a unei acțiuni din modelul de evaluare Bulios. Este un punct de plecare pentru propria analiză, nu o recomandare de investiții. Cum funcționează?
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Despre companie
Sensus Healthcare, Inc. (SRTS) is a company specializing in the development and provision of advanced technologies for the treatment of cancer and dermatological conditions. With over a decade of history, Sensus Healthcare focuses on innovative approaches, such as low-dose radiation therapy, that selectively target tumor cells and minimize effects on surrounding healthy tissues. Their technologies offer patients and physicians alternative treatment options with an emphasis on effectiveness and reduced invasiveness. Sensus Healthcare, Inc. (SRTS) contributes to the advancement of sophisticated treatment methods and the improvement of quality of life for patients with cancer and dermatological conditions. Sensus Healthcare, Inc. (SRTS) shares could be suitable for investors who want to support innovations in oncological and dermatological treatment and contribute to progress in therapeutic approaches.
Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.
Sector
Healthcare
Industry
Medical - Devices
CEO
Joseph C. Sardano
Employees
60
Headquarters
Boca Raton
Evenimente viitoare
Earnings
Upcoming earnings report